OrganOx develops medical technologies to enhance organ transplant outcomes, particularly through its metra® platform for liver and kidney transplants.

Abcuro, Inc. is a biotechnology company developing therapies for autoimmune diseases and cancer, with a focus on their lead candidate, ulviprubart, a monoclonal antibody for treating inclusion body myositis.

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.

Blue Earth Therapeutics develops clinical-stage PSMA-targeted radioligand therapies for improving prostate cancer treatment outcomes.

Candid Therapeutics, Inc. is a biotechnology company developing transformative therapies for autoimmune diseases.

Parse Biosciences is a company that develops and commercializes scalable single-cell sequencing technologies for use in over 1,000 labs globally, aiming to expand its product range and market presence with its recent $50 million funding.

Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.

Beta Bionics is a medical technology company that designs, develops, and commercializes autonomous insulin delivery systems to streamline diabetes management.